Filing Details
CytoDyn Inc. (OTC:CYDY) filed a Form 8-K with the Securities and Exchange Commission on October 19, 2026, disclosing a material event.
8k filedOTC:CYDY
CytoDyn Inc. (CYDY) Reports Material Event to SEC
CytoDyn Inc. (OTC:CYDY) filed a Form 8-K with the Securities and Exchange Commission on October 19, 2026, disclosing a material event.
At publication ·
What changed
CytoDyn Inc. (OTC:CYDY) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- CytoDyn Inc. filed a Form 8-K with the SEC on October 19, 2026, disclosing a material event requiring shareholder notification.
- The company's stock trades at $0.25 per share with a market capitalization of $408.9 million.
- 8-K filings report material events such as leadership changes, agreements, acquisitions, or asset sales between regular reports.
Market Context
CytoDyn Inc.'s stock currently trades at $0.25 with a market capitalization of $408.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CytoDyn Inc.'s stock.
All SEC filings for CytoDyn Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CYDY Stock Page
Frequently Asked Questions
Where can I read CYDY's SEC filings?
Browse all filings on our CYDY SEC filings page.
What types of SEC filings does CytoDyn Inc. file?
Public companies like CytoDyn Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.